重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2013年
25期
2955-2958
,共4页
动脉硬化%骨质疏松%阿仑膦酸钠%阿法骨化醇
動脈硬化%骨質疏鬆%阿崙膦痠鈉%阿法骨化醇
동맥경화%골질소송%아륜련산납%아법골화순
atherosclerosis%osteoporosis%alendronate sodium%alfacalcidol
目的:探讨阿仑膦酸钠及阿法骨化醇联合治疗对2型糖尿病(T2DM )合并骨质疏松老年女性患者动脉硬化的影响。方法:选取T2DM 合并骨质疏松老年女性28例作为骨质疏松组,T2DM 非骨质疏松老年女性25例作为对照组,给予骨质疏松组阿仑膦酸钠及阿法骨化醇联合治疗12个月,观察股骨颈和ward三角区骨密度(BMD)、T 值、踝臂指数(ABI)、心踝血管指数(CAVI)、颈动脉内膜中层厚度(IM T )、糖化血红蛋白、血脂、血压的变化。结果与对照组比较,骨质疏松组BMD、T值及ABI明显下降(P<0.01),而CAVI、IMT明显升高(P<0.05)。与治疗前比较,骨质疏松组治疗12个月后动脉硬化参数ABI、CAVI及IM T无明显变化,而股骨颈、w ard三角BM D、T 值明显升高( P<0.05);对照组的动脉硬化程度在12个月后较前加重( P<0.05),骨密度、T值无明显变化。结论:阿仑膦酸钠联合阿法骨化醇治疗T2DM合并骨质疏松老年女性患者能改善其动脉硬化参数,对其心脑血管疾病的防治有一定作用。
目的:探討阿崙膦痠鈉及阿法骨化醇聯閤治療對2型糖尿病(T2DM )閤併骨質疏鬆老年女性患者動脈硬化的影響。方法:選取T2DM 閤併骨質疏鬆老年女性28例作為骨質疏鬆組,T2DM 非骨質疏鬆老年女性25例作為對照組,給予骨質疏鬆組阿崙膦痠鈉及阿法骨化醇聯閤治療12箇月,觀察股骨頸和ward三角區骨密度(BMD)、T 值、踝臂指數(ABI)、心踝血管指數(CAVI)、頸動脈內膜中層厚度(IM T )、糖化血紅蛋白、血脂、血壓的變化。結果與對照組比較,骨質疏鬆組BMD、T值及ABI明顯下降(P<0.01),而CAVI、IMT明顯升高(P<0.05)。與治療前比較,骨質疏鬆組治療12箇月後動脈硬化參數ABI、CAVI及IM T無明顯變化,而股骨頸、w ard三角BM D、T 值明顯升高( P<0.05);對照組的動脈硬化程度在12箇月後較前加重( P<0.05),骨密度、T值無明顯變化。結論:阿崙膦痠鈉聯閤阿法骨化醇治療T2DM閤併骨質疏鬆老年女性患者能改善其動脈硬化參數,對其心腦血管疾病的防治有一定作用。
목적:탐토아륜련산납급아법골화순연합치료대2형당뇨병(T2DM )합병골질소송노년녀성환자동맥경화적영향。방법:선취T2DM 합병골질소송노년녀성28례작위골질소송조,T2DM 비골질소송노년녀성25례작위대조조,급여골질소송조아륜련산납급아법골화순연합치료12개월,관찰고골경화ward삼각구골밀도(BMD)、T 치、과비지수(ABI)、심과혈관지수(CAVI)、경동맥내막중층후도(IM T )、당화혈홍단백、혈지、혈압적변화。결과여대조조비교,골질소송조BMD、T치급ABI명현하강(P<0.01),이CAVI、IMT명현승고(P<0.05)。여치료전비교,골질소송조치료12개월후동맥경화삼수ABI、CAVI급IM T무명현변화,이고골경、w ard삼각BM D、T 치명현승고( P<0.05);대조조적동맥경화정도재12개월후교전가중( P<0.05),골밀도、T치무명현변화。결론:아륜련산납연합아법골화순치료T2DM합병골질소송노년녀성환자능개선기동맥경화삼수,대기심뇌혈관질병적방치유일정작용。
Objective To observe the effects of alendronate sodium and alfacalcidol on the parameters of atherosclerosis in old women with type 2 diabetes mellitus(T2DM ) complicating osteoporosis .Methods 28 old women with T2DM complicating osteopo-rosis were taken as the osteoporosis group and 25 old women with T2DM and without osteoporosis were taken as the control group .Alendronate sodium(70 mg/week) and alfacalcidol(0 .5 μg/d) were given to the osteoporosis group for 12 month .The pa-rameters of the bone mass density (BMD)of femoral neck and ,T value ,arkle brachial index (ABI) ,cardio-ankle vascular index (CAVI) and carotid artery intima-media thickness(IMT) ,blood fat and glycosylated hemoglobin were observed .Results Com-pared with the control group ,BMD ,T value and ABI in the osteoporosis group were significantly decreased (P<0 .01) ,while CAVI and IMT were obviously increased(P<0 .05) .Compared with before treatment ABI ,CAVI and IMT after 12 month treatment in the osteoporosis group had no significant changes ,but BMD and T value of femoral neck and ward triangle area were significantly increased(P<0 .05) ,the atherosclerosis degree after 12 months in the control group was significantly aggravated (P<0 .05) .BMD and T value had no obvious change .Conclusion Alendronate sodium combined with alfacalcidol for treating T 2DM complicating os-teoporosis can improve the atherosclerosis parameters and has certain role in preventing and treating cardiovascular and cerebrovas-cular diseases .